General considerations
Following decades of taxonomic upheaval, strong molecular phylogenetic evidence now indicates that the phylum Microspora is a monophyletic lineage within the Kingdom Fungi (review in Corradi & Keeling, 2009). Members of this clade are obligate, intracellular, spore-forming parasites. The unique and distinctive spores of these unicellular eukaryotes are minute, ranging from 2 to 20 µm in length. Although they are eukaryotic, microsporidian cells have several unusual characteristics, including a lack of organelles such as flagella, peroxisomes, mitochondria, and Golgi apparatus. Microsporidians also have 16S rather than 18S ribosomes. However, despite their relative simplicity, they can also be considered as marvels of structural and functional complexity, possessing adaptations for survival while outside their host, and also for intracellular parasitism. Within the spore is a diagnostic, exquisite extrusion apparatus, adapted for the penetration of host cells.
Louis Pasteur described the first microsporidian in the mid nineteenth century. He showed that Nosema bombycis caused ‘pebrine disease’ in silk-moth larvae, and provided recommendations to European silkworm farmers regarding control. Currently, a total of approximately 1300 species of microsporidians in 160 genera have been described. Following from modern advances in molecular diagnostics, it is likely that many more species await discovery. While most microsporidians are parasites of insects, they infect a wide range of other invertebrates, including nematodes, molluscs, annelids, and crustaceans. Microsporidians are present within all five classes of vertebrates, with 14 genera described from teleost fishes alone. Research involving microsporidians has traditionally focused on economically important species of insects (e.g., Nosema spp., review in Wittner & Weiss, 1999) and fish (e.g., Loma spp., review in Dyková, 2006). In recent years, this focus has expanded to include microsporidians that have been implicated as causative agents of opportunistic infections and emergent diseases in humans (review in Weiss, 2001).